Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Femke C C van Rhijn-Brouwer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Immunology Letters|November 21, 2017
Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?Femke C C van Rhijn-Brouwer, Julia Spierings, Jacob M van Laar
Current Opinion in Rheumatology|August 1, 2018
Hematopoietic stem-cell transplantation in systemic sclerosis: an updateJulia Spierings, Femke C C van Rhijn-Brouwer, Jacob M van Laar
Frontiers in Immunology|May 8, 2018
Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An UpdateLisanne Lutter, Julia Spierings, Femke C C van Rhijn-Brouwer, et al.
Angiogenesis|April 1, 2019
Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemiaHendrik Gremmels, Femke C C van Rhijn-Brouwer, Diana A Papazova, et al.
Journal of Vascular Surgery|December 16, 2017
Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemiaJoep G J Wijnand, Martin Teraa, Hendrik Gremmels, et al.
Current Rheumatology Reports|March 5, 2016
Cellular Therapies in Systemic Sclerosis: Recent ProgressFemke C C van Rhijn-Brouwer, Hendrik Gremmels, Joost O Fledderus, et al.
Rheumatology (Oxford, England)|December 7, 2019
Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient's perspectiveJulia Spierings, Femke C C van Rhijn-Brouwer, Carolijn J M de Bresser, et al.
Stem Cells International|January 15, 2020
Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney DiseaseFemke C C van Rhijn-Brouwer, Bas W M van Balkom, Diana A Papazova, et al.
BMJ Open|August 22, 2018
A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocolFemke C C van Rhijn-Brouwer, Hendrik Gremmels, Joost O Fledderus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Immunology Letters|November 21, 2017
Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?Femke C C van Rhijn-Brouwer, Julia Spierings, Jacob M van Laar
Current Opinion in Rheumatology|August 1, 2018
Hematopoietic stem-cell transplantation in systemic sclerosis: an updateJulia Spierings, Femke C C van Rhijn-Brouwer, Jacob M van Laar
Frontiers in Immunology|May 8, 2018
Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An UpdateLisanne Lutter, Julia Spierings, Femke C C van Rhijn-Brouwer, et al.
Angiogenesis|April 1, 2019
Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemiaHendrik Gremmels, Femke C C van Rhijn-Brouwer, Diana A Papazova, et al.
Journal of Vascular Surgery|December 16, 2017
Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemiaJoep G J Wijnand, Martin Teraa, Hendrik Gremmels, et al.
Current Rheumatology Reports|March 5, 2016
Cellular Therapies in Systemic Sclerosis: Recent ProgressFemke C C van Rhijn-Brouwer, Hendrik Gremmels, Joost O Fledderus, et al.
Rheumatology (Oxford, England)|December 7, 2019
Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient's perspectiveJulia Spierings, Femke C C van Rhijn-Brouwer, Carolijn J M de Bresser, et al.
Stem Cells International|January 15, 2020
Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney DiseaseFemke C C van Rhijn-Brouwer, Bas W M van Balkom, Diana A Papazova, et al.
BMJ Open|August 22, 2018
A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocolFemke C C van Rhijn-Brouwer, Hendrik Gremmels, Joost O Fledderus, et al.
Pageof 1